| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC8875 | Saxagliptin Featured | Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM and Ki of 1.3 nM. |
|
| DC7495 | SB-334867 HCl Featured | SB-334867 is a selective non-peptide orexin OX1 receptor antagonist with a pKb value of 7.2. |
|
| DC8419 | SB-334867 Featured | SB-334867 is a selective orexin-1 (OX1) receptor antagonist. |
|
| DC9690 | Sinogliatin (HMS5552, RO5305552) Featured | Sinogliatin (HMS5552, RO5305552) is a mall molecule glucokinase (GCK; GK) activator. |
|
| DCAPI1445 | strontium ranelate | Strontium Ranelate is a bone metabolism modulator that inhibits bone resorption while maintaining bone formation. Commonly used as an antiosteoporotic. |
|
| DC10581 | Succinobucol（AGI 1067) Featured | Succinobucol is a phenolic antioxidant with anti-inflammatory and antiplatelet effects. |
|
| DC5073 | TAK-875(Fasiglifam) Featured | TAK-875 is a potent, selective and orally bioavailable GPR40 agonist with EC50 of 0.072 μM. |
|
| DC4158 | Tranabant (MK-0364) | Taranabant is a highly selective cannabinoid-1 (CB1) receptor inverse agonist. |
|
| DC7515 | Teglicar Featured | Teglicar, in vitro and in animal models, reduces gluconeogenesis and improves glucose homeostasis, refreshing the interest in selective and reversible L-CPT1 inhibition as a potential antihyperglycemic approach. |
|
| DC7826 | Tofogliflozin hydrate | Tofogliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2). |
|
| DC8903 | Troglitazone | Troglitazone(CS-045), PPARγ agonist, is an anti-diabetic thiazolidinedione (TZD) with anti-inflammatory and anti-tumor activity. |
|
| DC9343 | ZLN024 (hydrochloride) | ZLN024 Hcl is a novel AMPK allosteric activator; activated α1β1γ1 and α2β1γ1 by around 2–2.5 fold with an EC50 of about 1–2 uM. IC50 value: 1-2 uM (EC50) [1] Target: AMPK activator ZLN024 activated AMPK in L6 myotubes and stimulated glucose uptake and |
|
| DC10320 | Saroglitazar (Magnesium) | Saroglitazar magnesium is a novel peroxisome proliferator-activated receptor (PPAR) agonist with predominant PPARα and moderate PPARγ activity with EC50 values of 0.65 pM and 3 nM in HepG2 cells, respectively. |
.gif)
|
| DC10322 | Saroglitazar | Saroglitazar is a novel peroxisome proliferator-activated receptor (PPAR) agonist with predominant PPARα and moderate PPARγ activity with EC50 values of 0.65 pM and 3 nM in HepG2 cells, respectively. |
|
| DC7163 | ZLN005 Featured | ZLN005 is a novel transcriptional regulator of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α). |
|
| DC1076 | Otenabant(CP945598.HCl) Featured | CP-945598 HCl is a potent and selective cannabinoid type 1 receptor antagonist with Ki of 0.7 nM. |
|
